Cargando…

Formulation of a Mapping Formula to Estimate Well-Being Utility from Clinical Subjective Well-Being Scales

PURPOSE: Cost-effective analysis is one of the most useful analyses for political decision-making in medicine under a limited budget. Although the data of the ICEpop CAPability measure for Adults (ICECAP-A) is sometimes essential for the measurement of cost effectiveness, such data are often lacking...

Descripción completa

Detalles Bibliográficos
Autores principales: Koreki, Akihiro, Nagaoka, Maki, Ninomiya, Akira, Mimura, Masaru, Sado, Mitsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642799/
https://www.ncbi.nlm.nih.gov/pubmed/36387041
http://dx.doi.org/10.2147/PRBM.S383266
_version_ 1784826387728695296
author Koreki, Akihiro
Nagaoka, Maki
Ninomiya, Akira
Mimura, Masaru
Sado, Mitsuhiro
author_facet Koreki, Akihiro
Nagaoka, Maki
Ninomiya, Akira
Mimura, Masaru
Sado, Mitsuhiro
author_sort Koreki, Akihiro
collection PubMed
description PURPOSE: Cost-effective analysis is one of the most useful analyses for political decision-making in medicine under a limited budget. Although the data of the ICEpop CAPability measure for Adults (ICECAP-A) is sometimes essential for the measurement of cost effectiveness, such data are often lacking in most clinical trials. Therefore, a conversion formula (ie mapping) derived from the values of clinical assessment scales into utility is required. PATIENTS AND METHODS: We used an internet survey where 500 general residents were asked to fill in four kinds of self-reported questionnaires [ICECAP-A, the Satisfaction with Life Scale (SWLS), Flourishing Scale (FS), and the Scale of Positive and Negative Experience (SPANE)]. A beta regression was conducted with the utility assessed by ICECAP-A as a dependent variable. RESULTS: We developed several mapping formulae depending on available questionnaires. These mapping formulae were well-validated in our validation sample. The models using a greater number of questionnaires tended to show better mapping. CONCLUSION: The mapping function of our formula was within the range of other reported mapping studies. We believe this formula is useful for cost effective analyses of several trials where utility data are lacking.
format Online
Article
Text
id pubmed-9642799
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-96427992022-11-15 Formulation of a Mapping Formula to Estimate Well-Being Utility from Clinical Subjective Well-Being Scales Koreki, Akihiro Nagaoka, Maki Ninomiya, Akira Mimura, Masaru Sado, Mitsuhiro Psychol Res Behav Manag Original Research PURPOSE: Cost-effective analysis is one of the most useful analyses for political decision-making in medicine under a limited budget. Although the data of the ICEpop CAPability measure for Adults (ICECAP-A) is sometimes essential for the measurement of cost effectiveness, such data are often lacking in most clinical trials. Therefore, a conversion formula (ie mapping) derived from the values of clinical assessment scales into utility is required. PATIENTS AND METHODS: We used an internet survey where 500 general residents were asked to fill in four kinds of self-reported questionnaires [ICECAP-A, the Satisfaction with Life Scale (SWLS), Flourishing Scale (FS), and the Scale of Positive and Negative Experience (SPANE)]. A beta regression was conducted with the utility assessed by ICECAP-A as a dependent variable. RESULTS: We developed several mapping formulae depending on available questionnaires. These mapping formulae were well-validated in our validation sample. The models using a greater number of questionnaires tended to show better mapping. CONCLUSION: The mapping function of our formula was within the range of other reported mapping studies. We believe this formula is useful for cost effective analyses of several trials where utility data are lacking. Dove 2022-11-04 /pmc/articles/PMC9642799/ /pubmed/36387041 http://dx.doi.org/10.2147/PRBM.S383266 Text en © 2022 Koreki et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Koreki, Akihiro
Nagaoka, Maki
Ninomiya, Akira
Mimura, Masaru
Sado, Mitsuhiro
Formulation of a Mapping Formula to Estimate Well-Being Utility from Clinical Subjective Well-Being Scales
title Formulation of a Mapping Formula to Estimate Well-Being Utility from Clinical Subjective Well-Being Scales
title_full Formulation of a Mapping Formula to Estimate Well-Being Utility from Clinical Subjective Well-Being Scales
title_fullStr Formulation of a Mapping Formula to Estimate Well-Being Utility from Clinical Subjective Well-Being Scales
title_full_unstemmed Formulation of a Mapping Formula to Estimate Well-Being Utility from Clinical Subjective Well-Being Scales
title_short Formulation of a Mapping Formula to Estimate Well-Being Utility from Clinical Subjective Well-Being Scales
title_sort formulation of a mapping formula to estimate well-being utility from clinical subjective well-being scales
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642799/
https://www.ncbi.nlm.nih.gov/pubmed/36387041
http://dx.doi.org/10.2147/PRBM.S383266
work_keys_str_mv AT korekiakihiro formulationofamappingformulatoestimatewellbeingutilityfromclinicalsubjectivewellbeingscales
AT nagaokamaki formulationofamappingformulatoestimatewellbeingutilityfromclinicalsubjectivewellbeingscales
AT ninomiyaakira formulationofamappingformulatoestimatewellbeingutilityfromclinicalsubjectivewellbeingscales
AT mimuramasaru formulationofamappingformulatoestimatewellbeingutilityfromclinicalsubjectivewellbeingscales
AT sadomitsuhiro formulationofamappingformulatoestimatewellbeingutilityfromclinicalsubjectivewellbeingscales